How Does Methadone Affect Your Kidneys?

Methadone is one of the gentler opioids when it comes to kidney health under normal therapeutic use, but it can cause serious kidney damage in specific circumstances, particularly overdose. Unlike many other opioids whose breakdown products accumulate dangerously in people with reduced kidney function, methadone’s metabolism relies heavily on the liver and gut, giving it a safety profile that has made it a preferred pain medication for patients who already have kidney disease. The picture gets more complicated, though, when you look at overdose scenarios, the drug’s effects on urine output and fluid balance, and the practical question of what dose adjustments matter for people whose kidneys are already struggling.

How Your Body Gets Rid of Methadone

Roughly 25 to 50 percent of a methadone dose leaves the body through the kidneys, while another 10 to 45 percent is excreted through the gastrointestinal tract.¹ What makes methadone unusual among opioids is that when the kidneys stop working well, the body shifts its excretion route. In people who produce no urine at all, methadone and its main breakdown product are excreted almost entirely through the gut. That built-in backup route is a big deal, because it means the drug does not pile up in the bloodstream the way many other pain medications do when kidney function drops.

The liver does most of the heavy lifting in breaking methadone down into its inactive metabolites. Because of this liver-dominant processing, the time it takes for your body to clear methadone does not change significantly even when kidney function is impaired.¹ Compare that to morphine and codeine, which produce active metabolites that the kidneys are responsible for clearing. When those metabolites build up in someone with poor kidney function, they can cause prolonged sedation, breathing problems, and other dangerous effects. Methadone’s metabolites, by contrast, are largely inactive, which is why nephrologists and pain specialists view it differently from most opioids.

Why Methadone Is Considered Safer for People With Kidney Disease

Reviews of opioid safety in kidney patients consistently place methadone in the “safer” category alongside fentanyl. One widely cited review recommended that morphine and codeine be avoided entirely in patients with kidney failure or those on dialysis, that hydromorphone and oxycodone be used only with caution and close monitoring, and that methadone and fentanyl appear safe to use.² That recommendation stems directly from the excretion flexibility described above: if your kidneys are barely filtering, methadone finds another way out of your body, while other opioids do not.

There is also a practical benefit for patients on dialysis. Methadone is very poorly removed by both peritoneal dialysis and hemodialysis. One study found that less than one percent of a daily methadone dose was pulled out during either type of dialysis.³ That might sound like a disadvantage, but it actually means patients on methadone maintenance do not need supplemental doses after dialysis sessions. Their blood levels stay relatively steady, which matters for both pain control and for people using methadone as part of opioid use disorder treatment. Drugs that get stripped out by dialysis create a rollercoaster of highs and withdrawal-like lows on treatment days, and methadone largely avoids that problem.

Dose Adjustments When Kidney Function Is Low

Even though methadone is considered safe for kidney patients in general, it is not a free pass to use any dose. For people whose kidney filtration rate has dropped very low, or whose bloodwork shows sharply elevated creatinine levels, a dose reduction is recommended. Specifically, a half-dose should be considered when the glomerular filtration rate falls to about 10 to 15 milliliters per minute and serum creatinine rises above roughly 8 mg/dL.¹ To put that in context, a normal filtration rate is above 90, and normal creatinine levels are usually under 1.2, so these thresholds apply only to people with severely compromised kidneys.

The rationale for the dose cut is not that methadone suddenly becomes toxic at low kidney function, but that the body’s overall handling of drugs becomes less predictable in advanced kidney disease. Fluid shifts, changes in blood proteins that carry drugs through the bloodstream, and the interplay between liver and kidney function all contribute to altered drug levels. At standard doses in a patient with very little remaining kidney function, even methadone’s relatively favorable profile can lead to excessive sedation or respiratory depression if the dose is not adjusted.

How Methadone Overdose Can Destroy Kidney Tissue

The biggest kidney threat from methadone is not the drug’s direct chemical effect on kidney cells, but rather what happens when someone overdoses and loses consciousness. A methadone overdose can cause a cascade of events that leads to rhabdomyolysis, a condition in which muscle tissue breaks down and floods the bloodstream with proteins the kidneys are not designed to handle in large quantities. The muscle breakdown protein myoglobin clogs the kidney’s filtering structures, and the resulting damage can cause acute kidney failure.

Research on how methadone triggers rhabdomyolysis points to several indirect pathways. When a person becomes unconscious from an overdose and lies in one position for an extended period, the weight of their own body compresses muscle tissue, cutting off blood supply and causing what is called compression necrosis. In addition, methadone overdose commonly causes respiratory depression, meaning breathing becomes dangerously slow and shallow. The resulting drop in oxygen levels forces muscles throughout the body to work harder with less fuel, and that oxygen starvation itself can damage muscle fibers. Pulmonary edema, a buildup of fluid in the lungs that sometimes accompanies overdose, compounds the hypoxia and worsens the muscle damage.⁴

A study of rhabdomyolysis cases in opioid overdose patients admitted to an intensive care unit in Iran found that methadone was the most commonly involved drug. Among the patients in that study, five died from severe kidney failure, all of whom were male, representing about 6.5 percent of the study group.⁵ The patients who developed rhabdomyolysis were most commonly in their twenties and thirties. These were not people with pre-existing kidney disease being treated carefully with adjusted doses. They were overdose cases, often involving illicit use, where prolonged unconsciousness was the mechanism driving kidney destruction.

How Opioids Change What Your Kidneys Do With Water and Salt

Beyond the overdose scenario, opioids including methadone have direct pharmacological effects on kidney function that are worth understanding even if they rarely cause permanent damage. Opioids interact with receptors throughout the body, and the kidneys have their own set of opioid receptors. Depending on which type of receptor is activated, the effects on the kidney can differ. Research has demonstrated that opioids produce changes in how the kidneys handle water and sodium, though the exact mechanisms behind these shifts are still not fully worked out.⁶

In practical terms, one of the most commonly noticed effects is a reduction in urine output. Opioids tend to promote the release of antidiuretic hormone, which tells the kidneys to hold on to water. If you have ever noticed reduced urination while taking an opioid, this is the mechanism. For most people on therapeutic doses, this effect is mild and reversible. But for people on long-term methadone maintenance, especially those who also have conditions like heart failure where fluid retention is already a concern, the cumulative effect on water balance is worth monitoring. Swollen ankles and increased body weight from retained fluid can sometimes be traced in part to the drug’s effect on kidney water handling.

Sodium handling is similarly affected. Opioids can blunt the kidney’s normal response to sodium loads, which can contribute to mild electrolyte shifts. Again, in healthy individuals at therapeutic doses, this rarely causes noticeable problems. It becomes clinically relevant in people who are already on the edge, whether from kidney disease, heart failure, liver disease, or the combination of multiple medications that affect fluid balance.

Urinary Retention and Bladder Effects

A related but distinct kidney-adjacent problem is urinary retention, the inability to fully empty the bladder. All opioids can cause this by reducing the muscle contractions that squeeze urine out of the bladder and by tightening the urethral sphincter. If urine backs up significantly, the pressure can theoretically damage the kidneys over time, a condition called obstructive nephropathy. In practice, most opioid-related urinary retention is recognized and treated before it reaches that point, but it is a real risk, especially in older men who may already have enlarged prostates.

Case reports have documented patients who developed urinary retention after starting opioid therapy and found that switching to methadone did not resolve the bladder dysfunction, even when it effectively managed their pain.⁷ This is a class effect of opioids rather than something unique to methadone. If you are on methadone and notice difficulty urinating, a weak stream, or a feeling that your bladder is not emptying completely, it is worth bringing up with your prescriber. Left untreated, chronic retention can lead to urinary tract infections and, in rare cases, upstream pressure on the kidneys.

The Overdose Risk Is Where the Real Kidney Danger Lives

It is worth emphasizing what the research collectively tells us, because the clinical picture is somewhat counterintuitive. At prescribed doses, methadone is considered one of the least kidney-damaging opioids available and is actively recommended for patients whose kidneys are already failing. The drug does not accumulate dangerously in kidney disease, it is not stripped away by dialysis, and its metabolites are not toxic to kidney tissue in the way that some other opioid metabolites are.

But in overdose, methadone’s kidney effects can be devastating, and the damage comes from the cascade that starts with unconsciousness. Prolonged immobility leads to muscle breakdown, muscle proteins overwhelm the kidneys, and acute kidney failure follows. The systematic review of methadone’s kidney toxicity found that virtually all reported cases of methadone-related kidney injury trace back to this indirect rhabdomyolysis pathway rather than to any direct chemical attack on kidney cells by methadone itself.⁴ That distinction has practical implications: the kidney risk from methadone is largely avoidable through safe dosing and overdose prevention, rather than something that accumulates insidiously over years of use.

What People on Long-Term Methadone Maintenance Should Know

If you are on methadone for opioid use disorder treatment or for chronic pain management, here is what the research means for your kidneys in practice. Routine kidney monitoring through standard blood work and urine tests is sensible, particularly if you have other risk factors for kidney disease like diabetes, high blood pressure, or hepatitis C. But methadone itself is unlikely to be the thing degrading your kidney function if you are taking it as prescribed.

People on methadone maintenance who also inject drugs face an additional set of kidney risks that are not caused by methadone itself but travel in the same population. Injection drug use carries the risk of infections that can seed the kidneys, and the adulterants in street drugs can cause their own form of kidney injury. Hepatitis C, which is common among people with a history of injection drug use, can damage the kidneys through immune-mediated mechanisms. If you have been on methadone maintenance and your kidney numbers come back abnormal, your doctor will likely look at these other factors before pointing at the methadone.

The fluid retention effects of opioids are cumulative with other medications. If you take methadone alongside blood pressure medications, antidepressants, or other drugs that affect fluid balance, you and your prescriber should keep an eye on your weight and look for signs of fluid overload. Simple blood tests that check sodium, potassium, and kidney function can catch problems early.

When Someone Overdoses and the Kidneys Are at Stake

For people who encounter methadone overdose situations, whether as bystanders, family members, or emergency responders, understanding the rhabdomyolysis pathway matters. The sooner an unconscious person is found and repositioned, the less time muscles spend being compressed, and the lower the risk of the kidney-damaging cascade. Naloxone reverses the opioid effects and can restore consciousness, but the muscle damage may already be underway if someone has been lying immobile for hours.

In the hospital, treatment for methadone-related rhabdomyolysis focuses on aggressive fluid resuscitation to flush myoglobin through the kidneys before it can cause further damage. Doctors monitor creatine kinase levels in the blood as a marker of muscle breakdown and watch kidney function closely. Most patients recover kidney function if the rhabdomyolysis is caught early, but severe cases can require temporary dialysis. The fatalities reported in the Iranian study involved patients who arrived with already-severe kidney failure, underscoring that the window for effective treatment is narrow once muscle breakdown is advanced.⁵

How Methadone Compares to Other Opioids for Kidney Safety

The comparison matters because people on opioid therapy often have choices, or at least their doctors do. Morphine is widely considered the worst opioid for kidney patients because its active metabolite, morphine-6-glucuronide, accumulates when the kidneys fail and can cause prolonged sedation and respiratory arrest. Codeine is similarly problematic. Hydromorphone and oxycodone fall in a middle ground, usable but requiring careful dose adjustments and monitoring.¹

Methadone and fentanyl sit at the safer end of this spectrum for people with kidney disease. Fentanyl shares methadone’s advantage of being primarily processed by the liver, though its short duration of action makes it less practical for chronic pain or maintenance therapy. Methadone’s long half-life, which ranges from roughly 8 to 60 hours depending on the individual, is both its clinical advantage and its risk: it provides steady, sustained coverage, but it also means that dosing errors or interactions with other drugs can lead to accumulation over days rather than hours.

The fact that the drugs safest for kidney patients are also the ones least removed by dialysis is a useful coincidence noted in the literature.³ It means that patients on dialysis who need opioid therapy can take methadone without worrying that their treatment sessions will strip the drug from their bloodstream, sparing them the cycles of pain breakthrough and re-dosing that dialysis-susceptible opioids would cause.

Heat, Dehydration, and Exercise on Methadone

One rarely discussed practical concern is the intersection of methadone use with conditions that independently stress the kidneys. Methadone can cause excessive sweating as a side effect, which contributes to dehydration if fluid intake does not keep pace. Dehydration on its own reduces blood flow to the kidneys and, in combination with methadone’s tendency to reduce urine output, can create conditions where the kidneys are working with less fluid throughput than normal. For someone exercising vigorously in hot weather while on methadone, the combination of sweating, reduced thirst perception (opioids can blunt thirst signals), and altered kidney water handling could theoretically compound into clinically meaningful dehydration.

None of this means you need to avoid physical activity on methadone. Rather, it means paying attention to hydration is more important than it might seem. Keeping fluid intake consistent, watching for dark urine as a sign of dehydration, and being aware that the drug’s side effects might mask some of your body’s usual thirst cues are all practical steps. People in methadone maintenance programs who work physically demanding outdoor jobs in warm climates may find this particularly relevant.